Skip to main content

Advertisement

SpringerLink
Log in

Studies on bone mineral metabolism in congenital adrenal hyperplasia Part II Serum osteocalcin level: Its relation to linear growth and skeletal maturation

  • Original Articles
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

A study was carried out to examine whether the level of serum osteocalcin (OC) reflects the response of bone growth to treatment in patients with congenital adrenal hyperplasia (CAH) in six prepubertal girls (21-hydroxylase deficiency) treated with hydrocortisone 13–33mg/m2/day and fludrocortisone 0.05–0.1mg/day. The relationships between biochemical parameters including serum OC, plasma testosterone, insulin-like growth factor I and 17-hydroxyprogesterone, with linear growth velocity SD score for chronological age and rate of skeletal maturation (ratio of bone age to chronological age) were serially assessed at three or over month intervals for three years. The statistically most significant correlation was found between OC level and growth velocity (r=0.55, p<0.001), compared with the levels of testosterone (r=0.45, p<0.05), 17-hydroxyprogesterone (r=0.33, p=0.053) and insulin-like growth factor I (r=0.10). In each patient, the serum OC level seemed to change in accordance with the growth velocity and the rate of skeletal maturation; a rise in OC level indicate an increased growth velocity with skeletal maturation, and a reduction of OC indicated the reverse. These OC responses were thought to be influenced by treatment condition (under/overtreatment). It may be that fluctuations in the level of serum OC are an indicator of the responses of bone to treatment in CAH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dimartino-Nardi J., Stoner E., O'Connell A., New M.I.: The effect of treatment on final height in classical congenital adrenal hyperplasia. Acta Endocrinol. 279 (Suppl): 305–314, 1986.

    CAS  Google Scholar 

  2. Tanae A., Hibi I.: Unresolved problems in treatment of congenital adrenal hyperplasia. Acta Paediatr. Jpn 30 (Suppl): 93–98, 1988.

    PubMed  Google Scholar 

  3. Young M.C., Hughes I.A.: Growth and body proportions in congenital adrenal hyperplasia. Arch. Dis.Child. 64: 1554–1558, 1989.

    CAS  PubMed  Google Scholar 

  4. Rappaport R., Bouthreuil E., Marti-Henneberg C., Basmaciogullari A.: Linear growth rate, bone maturation and growth hormone secretion in prepubertal children with congenital adrenal hyperplasia. Acta Paediatr.Scand. 62: 513–9, 1973.

    CAS  PubMed  Google Scholar 

  5. Klingensmith G.J., Garcia S.C., Jones H.W., Migeaon C.J., Blizzard R.M.: Glucocorticoid treatment of girls with congenital adrenal hyperplasia: Effect on height, sexual maturation, and fertility. J.Pediatr. 90: 996–1004, 1977.

    CAS  PubMed  Google Scholar 

  6. Young M.C., Hughes I.A.: Response to treatment of congenital adrenal hyperplasia in infancy. Arch.Dis.Child. 65: 441–444, 1990.

    CAS  PubMed  Google Scholar 

  7. Hosaka A.: Studies on bone mineral metabolism in congenital adrenal hyperplasia. Part I. Effect of long-term corticosteroid therapy on bone mineral metabolism. J Bone Mineral Metab 10:28–162, 1992.

    Google Scholar 

  8. Hughes IA. Management of congenital adrenal hyperplasia. Arch.Dis.Child. 63: 1399–404, 1988.

    CAS  PubMed  Google Scholar 

  9. Arisaka O., Shimura N., Nakayama Y., Arisaka M., Yabuta K.: Speichel-17-Hydroxyprogesteron-Konzentration zur Therapieuberwachung beiangeborener Nebennierenhyperplasie. Dtsch Med. Wschr. 113: 1913–1915, 1988.

    CAS  PubMed  Google Scholar 

  10. Epstein S.: Serum and urinary markers of bone remodelling: assessment of bone turnover. Endocrinol.Rev. 9: 437–449, 1988.

    CAS  Google Scholar 

  11. Delmas P.D., Chatelain P., Malaval L., Bonne G.: Serum bone GLA-protein in growth hormone deficient children. J. Bone.Mineral Res. 1: 333–338, 1986.

    CAS  Google Scholar 

  12. Nishiyama S., Tomoeda S., Ikuta M., Ohta T., Matsuda I.: Bone metabolism during treatment with growth hormone in patients with growth hormone deficiency and delayed adolescence. Acta Paediatr.Scand. 356 (Suppl): 141, 1989.

    Google Scholar 

  13. Johansen J.S., Jensen S.B., Riis B.J., Rasmussen L., Zachmann M., Christiansen C.: Serum bone Gla protein: A potential marker of growth hormone (GH) deficiency and the response to GH therapy. J.Clin.Endocrinol.Metab. 71: 122–1226,1990.

    CAS  PubMed  Google Scholar 

  14. Johansen J.S., Giwercman A., Hartwell D., Nielsen C.T., Price P.A., Christiansen C., Skakkebaek N.E.: Serum bone Gla-protein as a marker of bone growth in children and adolescents: Correlation with age, height, serum insulin-like growth factor I, and serum testosterone. J.Clin.Endocrinol.Metab. 67: 273–278, 1988.

    CAS  PubMed  Google Scholar 

  15. Reid I.R., Chapman G.E., Fraser T.R.C., Davies A.D., Surus A.S., Meyer J., Huq N.L., Ibbertson H.K.: Low serum osteocalcin levels in glucocorticoid treated asthmatics. J.Clin.Endocrinol.Metab. 62: 379–383, 1986.

    CAS  PubMed  Google Scholar 

  16. Niimi H., Nishioka T., Kumayama H., Nakajima H.: Serum osteocalcin in normal children and children with glucocorticoid-induced osteoporosis. J. Bone.Mineral.Metab. 6: 38–42, 1988.

    Google Scholar 

  17. Tanner J.M., Whitehouse R.H., Cameron N., Marshall W.A., Healy M.J.R., Goldstein H.: Assessment of skeletal maturation and prediction of adult height (TW2 method). New York: Academic Press, 1983.

    Google Scholar 

  18. Hosaka A., Arisaka O., Arisaka M., Tokita A., Shimura N., Nakayama Y., Yabuta K., Kawaguchi Y.: Bone mineral densities and serum osteocalcin levels in adolescent male hypogonadism. J.Clin.Exp.Med. 149: 523–524, 1989. (in Japanese, English abstr.)

    CAS  Google Scholar 

  19. Appan S., Hindmarch P.C., Brook C.G.D.: Monitoring treatment in congenital adrenal hyperplasia. Arch.Dis.Child. 64: 1235–1239, 1989.

    CAS  PubMed  Google Scholar 

  20. Cavallo A., Furlanetto R.W., Meyer W.J. III.: Plasma insulin-like growth factor I levels during treatment of congenital adrenal hyperplasia. Hormone Res. 34: 23–26, 1990.

    CAS  PubMed  Google Scholar 

  21. Isaksson O.G.P., Lindahl A., Nilsson A., Isgaard J.: Mechanism of the stimulatory effects of growth hormone on longitudinal bone growth. Endocrinol.Rev. 8:426–438, 1987.

    CAS  Google Scholar 

  22. Colvard D.S., Eriksen E.F., Keeting P.E., Wilson E.M., Lubahn D.B. French F.S., Riggs L., Spelsberg T.C.: Identification of androgen receptors in normal human osteoblast-like cells.Proc. Natl.Acad.Sci. U.S.A.: 86: 854–857, 1989.

    CAS  PubMed  Google Scholar 

  23. Attie K.M., Ramirez N.R., Conte F.A., Kaplan S.L., Grunbach M.M.: The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: evidence for a direct role of sex steroids. J.Clin.Endocrinol.Metab. 71: 975–983, 1990.

    CAS  PubMed  Google Scholar 

  24. Arisaka O., Arisaka M., Hosaka A., Shimura N., Yabuta K.: Effect of testosterone on radial bone mineral density in adolescent male hypogonadism. Acta Paediatr.Scand. 80: 378–380, 1991.

    CAS  PubMed  Google Scholar 

  25. Spector T.D., Thompson P.W., Perry L.A., McGarrigle H.H., Edwards A.C.: The relationship between sex steroids and bone mineral content in women soon after the menopause. Clin.Endocrinol. 34: 37–41, 1991.

    CAS  Google Scholar 

  26. Hyams J.S., Carey D.E.: Corticosteroids and growth. J.Pediatr. 113: 249–254, 1988.

    CAS  PubMed  Google Scholar 

  27. Linder B.L., Esteban N.V., Yergey A.L., Winterer J.C., Loriaux D.L., Cassorla F.: Cortisol production rate in childhood and adolescence. J.Pediatr. 117: 892–896, 1990.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatrics, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113, Tokyo, Japan

    Atsuto Hosaka MD & Osamu Arisaka MD

Authors
  1. Atsuto Hosaka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Osamu Arisaka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Hosaka, A., Arisaka, O. Studies on bone mineral metabolism in congenital adrenal hyperplasia Part II Serum osteocalcin level: Its relation to linear growth and skeletal maturation. J Bone Miner Metab 10, 33–38 (1992). https://doi.org/10.1007/BF02378981

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02378981

Key Words

Search

Navigation